These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19705430)

  • 1. Quality of life and use of red cell transfusion in patients with myelodysplastic syndromes. A systematic review.
    Pinchon DJ; Stanworth SJ; Dorée C; Brunskill S; Norfolk DR
    Am J Hematol; 2009 Oct; 84(10):671-7. PubMed ID: 19705430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in transfusion-dependent patients with myelodysplastic syndromes: a prospective study to assess the impact of iron chelation therapy.
    Efficace F; Santini V; La Nasa G; Cottone F; Finelli C; Borin L; Quaresmini G; Di Tucci AA; Volpe A; Cilloni D; Quarta G; Sanpaolo G; Rivellini F; Salvi F; Molteni A; Voso MT; Alimena G; Fenu S; Mandelli F; Angelucci E
    BMJ Support Palliat Care; 2016 Mar; 6(1):80-8. PubMed ID: 25204541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting health-related quality of life in patients with myelodysplastic syndromes - Current knowledge and lessons to be learned.
    Oliva EN; Platzbecker U; Fenaux P; Garcia-Manero G; LeBlanc TW; Patel BJ; Kubasch AS; Sekeres MA
    Blood Rev; 2021 Nov; 50():100851. PubMed ID: 34088518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes.
    Jansen AJ; Essink-Bot ML; Beckers EA; Hop WC; Schipperus MR; Van Rhenen DJ
    Br J Haematol; 2003 Apr; 121(2):270-4. PubMed ID: 12694248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical, quality of life, and economic consequences of chronic anemia and transfusion support in patients with myelodysplastic syndromes.
    Platzbecker U; Hofbauer LC; Ehninger G; Hölig K
    Leuk Res; 2012 May; 36(5):525-36. PubMed ID: 22300879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-perception of symptoms of anemia and fatigue before and after blood transfusions in patients with myelodysplastic syndromes.
    Ryblom H; Hast R; Hellström-Lindberg E; Winterling J; Johansson E
    Eur J Oncol Nurs; 2015 Apr; 19(2):99-106. PubMed ID: 25488465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for achieving transfusion independence in myelodysplastic syndromes.
    Thomas ML
    Eur J Oncol Nurs; 2007 Apr; 11(2):151-8. PubMed ID: 16935559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes.
    Caocci G; La Nasa G; Efficace F
    Expert Rev Hematol; 2009 Feb; 2(1):69-80. PubMed ID: 21082996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peri-transfusion quality-of-life assessment for patients with myelodysplastic syndromes.
    Abel GA; Klepin HD; Magnavita ES; Jaung T; Lu W; Shallis RM; Hantel A; Bahl NE; Dellinger-Johnson R; Winer ES; Zeidan AM
    Transfusion; 2021 Oct; 61(10):2830-2836. PubMed ID: 34251040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell transfusion in myelodysplastic syndromes: A systematic review.
    Kaka S; Jahangirnia A; Beauregard N; Davis A; Tinmouth A; Chin-Yee N
    Transfus Med; 2022 Feb; 32(1):3-23. PubMed ID: 34927286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the rationale for red cell transfusion in myelodysplastic syndrome patients: emerging data and future insights.
    Finelli C; Parisi S; Paolini S
    Expert Rev Hematol; 2022 May; 15(5):411-421. PubMed ID: 35549626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Red blood cell transfusions and iron overload in the treatment of patients with myelodysplastic syndromes.
    Jabbour E; Kantarjian HM; Koller C; Taher A
    Cancer; 2008 Mar; 112(5):1089-95. PubMed ID: 18186499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of anaemia on health-related quality of life and cardiac remodelling in patients with lower risk myelodysplastic syndromes. Results of GlobQoL study.
    Ramos F; Pedro C; Tormo M; de Paz R; Font P; Luño E; Caballero M; Solano F; Almagro M; Xicoy B; Jiménez M
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 26729645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry.
    Buckstein R; Chodirker L; Yee KWL; Geddes M; Leitch HA; Christou G; Banerji V; Leber B; Khalaf D; St-Hilaire E; Finn N; Nevill T; Keating MM; Storring J; Parmentier A; Thambipillai A; Tang D; Westcott C; Cameron C; Spin P
    Leuk Lymphoma; 2023 Mar; 64(3):651-661. PubMed ID: 36606533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common troublesome symptoms and their impact on quality of life in patients with myelodysplastic syndromes (MDS): results of a large internet-based survey.
    Steensma DP; Heptinstall KV; Johnson VM; Novotny PJ; Sloan JA; Camoriano JK; Niblack J; Bennett JM; Mesa RA
    Leuk Res; 2008 May; 32(5):691-8. PubMed ID: 18054795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion independence in patients with myelodysplastic syndromes: impact on outcomes and quality of life.
    Balducci L
    Cancer; 2006 May; 106(10):2087-94. PubMed ID: 16607649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry.
    Waszczuk-Gajda A; Mądry K; Machowicz R; Drozd-Sokołowska J; Stella-Hołowiecka B; Mital A; Obara A; Szmigielska-Kapłon A; Sikorska A; Subocz E; Jędrzejczak WW; Dwilewicz-Trojaczek J
    Adv Clin Exp Med; 2016; 25(4):633-41. PubMed ID: 27629836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outpatient transfusions for myelodysplastic syndromes.
    Wood EM; McQuilten ZK
    Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):167-174. PubMed ID: 33275745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Transfusions in myelodysplastic syndromes].
    Rose C
    Transfus Clin Biol; 2017 Sep; 24(3):209-215. PubMed ID: 28651884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing health-related quality of life in gynecologic oncology: a systematic review of questionnaires and their ability to detect clinically important differences and change.
    Luckett T; King M; Butow P; Friedlander M; Paris T
    Int J Gynecol Cancer; 2010 May; 20(4):664-84. PubMed ID: 20442592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.